Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    178% Intraday Surge: This US Biopharma Stock Skyrockets After Eye Disease Drug Clears Key Hurdle

    8 hours ago

    Kodiak said the completion of five successful Phase 3 trials positions the company to submit the treatments for US Food and Drug Administration approval later this year.
    Click here to Read More
    Previous Article
    Coforge Appoints Akhil Gupta As Chairperson Days After Key Board Exits
    Next Article
    Ola Electric Board Approves Rights Issue Of Up To Rs 1,000 Crore; Promoter To Participate

    Related Business Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment